FY13 Prescription Drug Monitoring Program (PDMP)

In FY 2013, the Harold Rogers Prescription Drug Monitoring Program (PDMP) expanded to provide funding to localities to assemble a local collaborative effort of public health and criminal justice professionals to pilot innovative ways to use PDMP and other data to inform prevention, treatment, and enforcement efforts.

The PDMP assists states with the implementation or enhancement of tribes' and localities' use of the PDMP to: build a state-level data collection and analysis system to enhance the capacity of regulatory and law enforcement agencies and public health officials for future prevention efforts; enhance existing programs' abilities to analyze and use collected data to identify drug abuse trends, identify and address sources of diversion, and increase the number of users of the PDMP; facilitate and participate in national evaluation efforts to assess efficiency and effectiveness; plan, implement, and increase the exchange of information under the PDMP Information Exchange (PMIX) Architecture among states to prevent cross-border diversion; assess the efficiency and effectiveness of state-level programs to make improvements and encourage additional states to implement programs; enhance collaborations with law enforcement, prosecutors, treatment professionals, the medical community, pharmacies, and regulatory boards to establish a comprehensive PDMP strategy; enable federally recognized tribal governments to establish the policy, legal, and technological infrastructure to share PDMP data from health care facilities with the appropriate state PDMP; and pilot a local collaborative effort between public health and criminal justice professionals to collect and analyze various sources of data to determine best practices for sharing data, regulatory schemes, deconfliction strategies, intelligence gathering, prioritization of treatment, and prevention efforts for at-risk individuals and communities. Data should be used to identify areas at greatest risk for prescription drug abuse and overdose deaths and create data-driven responses at the local level to include education, outreach, treatment, and enforcement.

The grant recipient will use the implementation and enhancement grant to establish and build a data collection and analysis system; develop an infrastructure to support programmatic activities; facilitate the exchange of information and collected prescription data and other scheduled chemical products among states; facilitate the establishment of collaborations; develop a training program for system users; produce and disseminate educational materials; and assess the efficiency and effectiveness of the program. Funds shall also be used to enhance the functioning of a data collection and analysis system; enhance an existing educational or training program; support collaborations with law enforcement and prosecutors or public health officials; support collaborations with treatment providers and drug courts; facilitate electronic information sharing among states in compliance with the National PMIX Architecture; expand monitoring to Schedules II, III, IV, and V; develop or enhance the capacity to provide unsolicited reports of controlled substance prescribing to authorized individuals or entities; and assess the efficiency and effectiveness of the program. If proposing to assess the efficiency and effectiveness of a program, recipients are encouraged to partner with local universities and/or state agencies in order to evaluate the program as it relates to prescription drug diversion and overdose. CA/NCF